Home › Funds › MADDEN SECURITIES Corp › GSK
MADDEN SECURITIES Corp position in GSK
GSK PLC · Health Care
MADDEN SECURITIES Corp reported holding 48,780 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.62% of its reported portfolio and ranking #41 among its reported holdings. MADDEN SECURITIES Corp has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How MADDEN SECURITIES Corp's GSK position evolved
MADDEN SECURITIES Corp first disclosed a stake in GSK in Q4 2024 at 87,430 shares (US$3.0M). The position peaked in Q1 2025 at 106,830 shares, worth US$4.1M. Across 8 filings, MADDEN SECURITIES Corp increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 48,780 shares valued at US$2.3M — a reduction of -4,650 shares quarter over quarter.. Notable position changes include a 40% trim in Q3 2025 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 87.43K | $2.96M | New |
| Q1 2025 | 106.83K | $4.14M | Add |
| Q2 2025 | 96.91K | $3.72M | Reduce |
| Q3 2025 | 57.73K | $2.49M | Reduce |
| Q4 2025 | 57.43K | $2.82M | Reduce |
| Q1 2026 | 57.18K | $3.16M | Hold |
| Q2 2026 | 53.43K | $2.80M | Reduce |
| Q3 2026 | 48.78K | $2.35M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 20 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.19M sh · $1.21B · Q3 2026
- JTC Employer Solutions Trustee Ltd 8.08M sh · $389.17M · Q3 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.92M sh · $188.73M · Q3 2026
- EQUITY INVESTMENT CORP 3.56M sh · $171.52M · Q3 2026
More on MADDEN SECURITIES Corp
FAQ
How long has MADDEN SECURITIES Corp held GSK?
MADDEN SECURITIES Corp has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is MADDEN SECURITIES Corp's current position in GSK?
As of Q3 2026, MADDEN SECURITIES Corp holds 48.78K shares of GSK (GSK PLC), valued at $2.35M, representing 0.62% of its reported portfolio and ranking #41.
Has MADDEN SECURITIES Corp been buying or selling GSK?
In the latest 13F filing (Q3 2026), MADDEN SECURITIES Corp reduced its position in GSK. The position peaked in Q1 2025 at 106.83K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.